Effect of carbon dioxide on erythromycin

Area of Science:

• Pharmaceutical Science
• Analytical Chemistry
• Microbiology

Background:

• Erythromycin is a widely used antibiotic.
• Understanding factors affecting its stability is crucial for effective therapeutic use.
• Carbon dioxide (CO2) is a common atmospheric component that may interact with pharmaceuticals.

Purpose of the Study:

• To investigate the impact of carbon dioxide (CO2) exposure on erythromycin stability.
• To compare the effects of CO2 and air on erythromycin solutions and saturated disks.
• To evaluate the influence of CO2 on erythromycin bioactivity assays.

Main Methods:

• Erythromycin solutions and saturated disks were exposed to CO2 and air atmospheres for 18 hours.
• Deterioration was assessed by measuring remaining erythromycin activity.
• Bioactivity assays were performed in both CO2 and ambient air environments.

Main Results:

• Erythromycin solutions showed minimal deterioration when exposed to CO2 or air.
• Saturated erythromycin disks exhibited greater deterioration, with slightly more degradation in the presence of CO2.
• The most significant reduction in erythromycin activity was observed when assays were conducted in a CO2 environment.

Conclusions:

• Erythromycin solutions are relatively stable under short-term CO2 or air exposure.
• Erythromycin's solid form (saturated disks) is more susceptible to degradation by CO2.
• CO2 significantly interferes with erythromycin bioactivity assays, potentially leading to underestimation of antibiotic potency.